Mr. Schmalz provides consulting services for the marketing and business development segment of diagnostics.  His expertise is in the area of molecular diagnostics with an emphasis on infectious diseases and oncology. 

Mr. Schmalz has a BS in Marketing and English from the University of Maryland at College Park.  In addition to his college degrees, Mr. Schmalz has completed executive management courses at Northwestern University’s Kellogg Business School.  His extensive business experience in the field of diagnostics gained him a nomination to join the Board of Directors for the Biomedical Marketing Association (BMA) where he served as a board member from 2001-2004.  Mr. Schmalz has 18 years of marketing and business development experience in the field of diagnostic for major fortune 100 companies including: Abbott Diagnostics, Chiron Diagnostics, Bayer Diagnostics and Laboratory Corporation of America (LabCorp).

Mr. Schmalzs’ background is particularly useful for clients with biomedical products (reagents & instruments) that are either IVD or Pre-IVD (Analyte Specific Reagent - ASR) that are interested in commercializing their operations in the US.  The commercialization process may include partnering with a major reference laboratory as a distribution arm or licensing technology rights to laboratories / companies for development of their own ASR.   Mr. Schmalzs’ experience also includes the development and implementation of comprehensive marketing plans and branding strategies for launching new products in the US.